Advance market commitment (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Advance market commitment" in English language version.

refsWebsite

Global rank English rank

8doi.org

2^nd place

8worldcat.org

5^th place

4semanticscholar.org

11^th place

8^th place

3nih.gov

4^th place

3gavi.org

low place

3msf.org

low place

2biomedcentral.com

2,747^th place

7,129^th place

1unicef.org

1,791^st place

1,568^th place

1cgdev.org

low place

1aeaweb.org

7,762^nd place

5,451^st place

1jstor.org

26^th place

20^th place

1uchicago.edu

230^th place

214^th place

1wiley.com

222^nd place

297^th place

1web.archive.org

1^st place

1who.int

195^th place

302^nd place

1nature.com

234^th place

397^th place

1indiaeducationdiary.in

low place

1politico.com

312^th place

197^th place

1frontierclimate.com

low place

1theatlantic.com

228^th place

158^th place

1globalcoolingprize.org

low place

aeaweb.org

pubs.aeaweb.org

Kremer, Michael; Levin, Jonathan; Snyder, Christopher M. (2020-05-01). "Advance Market Commitments: Insights from Theory and Experience". AEA Papers and Proceedings. 110: 269–273. doi:10.1257/pandp.20201017. ISSN 2574-0768.

biomedcentral.com

globalizationandhealth.biomedcentral.com

Gareth, M.J. (2022). "Reducing demand uncertainty in health innovation". Globalization and Health. 18 (1): 51.
Gareth, M.J. (2022). "Reducing demand uncertainty in health innovation". Globalization and Health. 18 (1): 51.

cgdev.org

"Making Markets for Vaccines: Ideas to Action". Center For Global Development. Retrieved 2023-06-23.

doi.org

Kremer, Michael; Levin, Jonathan; Snyder, Christopher M. (2020-05-01). "Advance Market Commitments: Insights from Theory and Experience". AEA Papers and Proceedings. 110: 269–273. doi:10.1257/pandp.20201017. ISSN 2574-0768.
Kremer, Michael (1998). "Patent Buyouts: A Mechanism for Encouraging Innovation". The Quarterly Journal of Economics. 113 (4): 1137–1167. doi:10.1162/003355398555865. ISSN 0033-5533. JSTOR 2586977. S2CID 31023203.
Kremer, Michael (January 2000). "Creating Markets for New Vaccines. Part I: Rationale". Innovation Policy and the Economy. 1: 35–72. doi:10.1086/ipe.1.25056141. ISSN 1531-3468. S2CID 153622261.
Kvåle, Gunnar (September 2001). "Tackling the diseases of poverty". The Lancet. 358 (9284): 845–846. doi:10.1016/s0140-6736(01)05996-7. ISSN 0140-6736. PMID 11570414.
Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; Lee, Jean; Levine, Ruth; Weizsäcker, Georg; Williams, Heidi (2006-10-02). "Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness". Health Economics. 16 (5) (published May 2007): 491–511. doi:10.1002/hec.1176. ISSN 1057-9230. PMID 17013993. S2CID 10511922.
Nayar, Anjali (2011-02-11). "Pneumococcal vaccine rolls out in developing world". Nature. doi:10.1038/news.2011.89. ISSN 1476-4687.
Usher, Ann Danaiya (May 18, 2019). "Low-cost pneumonia vaccine breaks into global market". The Lancet. 393 (10185): 2025–2026. doi:10.1016/s0140-6736(19)31084-0. ISSN 0140-6736. PMID 31106739. S2CID 155105175.
Kremer, Michael; Williams, Heidi (2010). "Incentivizing Innovation: Adding to the Tool Kit". Innovation Policy and the Economy. 10: 1–17.

frontierclimate.com

"An advance market commitment to accelerate carbon removal". frontierclimate.com. Retrieved 2022-09-30.

gavi.org

"GAVI partners fulfill promise to fight pneumococcal disease". gavi.org. Archived from the original on 13 January 2011.
"Supply agreements". www.gavi.org. 2018-06-06. Retrieved 2024-02-16.
Dalberg (15 October 2021). Gavi PCV AMC pilot: 2nd Outcomes and Impact Evaluation (PDF).

globalcoolingprize.org

"Global Cooling Prize".

indiaeducationdiary.in

"Pneumonia vaccine price drops dramatically for lower-income countries thanks to the Gavi pneumococcal Advance Market Commitment". India Education | Latest Education News | Global Educational News | Recent Educational News. 2020-06-17. Retrieved 2024-02-16.

jstor.org

Kremer, Michael (1998). "Patent Buyouts: A Mechanism for Encouraging Innovation". The Quarterly Journal of Economics. 113 (4): 1137–1167. doi:10.1162/003355398555865. ISSN 0033-5533. JSTOR 2586977. S2CID 31023203.

msf.org

"Access: MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine | MSF". Médecins Sans Frontières (MSF) International. 12 November 2015. Retrieved 2024-02-16.
"Gavi should stop awarding special funds to Pfizer and GSK for pneumonia vaccine". Médecins Sans Frontières (MSF) International. 26 August 2019. Retrieved 2024-02-16.
"Pfizer and GSK should not get huge subsidy for pneumonia vaccine | MSF". Médecins Sans Frontières (MSF) International. 3 December 2019. Retrieved 2024-02-16.

nature.com

Nayar, Anjali (2011-02-11). "Pneumococcal vaccine rolls out in developing world". Nature. doi:10.1038/news.2011.89. ISSN 1476-4687.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kvåle, Gunnar (September 2001). "Tackling the diseases of poverty". The Lancet. 358 (9284): 845–846. doi:10.1016/s0140-6736(01)05996-7. ISSN 0140-6736. PMID 11570414.
Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; Lee, Jean; Levine, Ruth; Weizsäcker, Georg; Williams, Heidi (2006-10-02). "Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness". Health Economics. 16 (5) (published May 2007): 491–511. doi:10.1002/hec.1176. ISSN 1057-9230. PMID 17013993. S2CID 10511922.
Usher, Ann Danaiya (May 18, 2019). "Low-cost pneumonia vaccine breaks into global market". The Lancet. 393 (10185): 2025–2026. doi:10.1016/s0140-6736(19)31084-0. ISSN 0140-6736. PMID 31106739. S2CID 155105175.

politico.com

"Opinion | Advance Market Commitments Worked for Vaccines. They Could Work for Carbon Removal, Too". Politico. 22 December 2021. Retrieved 2022-09-30.

semanticscholar.org

api.semanticscholar.org

Kremer, Michael (1998). "Patent Buyouts: A Mechanism for Encouraging Innovation". The Quarterly Journal of Economics. 113 (4): 1137–1167. doi:10.1162/003355398555865. ISSN 0033-5533. JSTOR 2586977. S2CID 31023203.
Kremer, Michael (January 2000). "Creating Markets for New Vaccines. Part I: Rationale". Innovation Policy and the Economy. 1: 35–72. doi:10.1086/ipe.1.25056141. ISSN 1531-3468. S2CID 153622261.
Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; Lee, Jean; Levine, Ruth; Weizsäcker, Georg; Williams, Heidi (2006-10-02). "Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness". Health Economics. 16 (5) (published May 2007): 491–511. doi:10.1002/hec.1176. ISSN 1057-9230. PMID 17013993. S2CID 10511922.
Usher, Ann Danaiya (May 18, 2019). "Low-cost pneumonia vaccine breaks into global market". The Lancet. 393 (10185): 2025–2026. doi:10.1016/s0140-6736(19)31084-0. ISSN 0140-6736. PMID 31106739. S2CID 155105175.

theatlantic.com

Meyer, Robinson (2022-04-13). "We've Never Seen a Carbon-Removal Plan Like This Before". The Atlantic. Retrieved 2022-09-30.

uchicago.edu

journals.uchicago.edu

Kremer, Michael (January 2000). "Creating Markets for New Vaccines. Part I: Rationale". Innovation Policy and the Economy. 1: 35–72. doi:10.1086/ipe.1.25056141. ISSN 1531-3468. S2CID 153622261.

unicef.org

"COVID-19 Market Dashboard | UNICEF Supply Division". www.unicef.org. Retrieved 2024-01-31.

web.archive.org

"GAVI partners fulfill promise to fight pneumococcal disease". gavi.org. Archived from the original on 13 January 2011.

who.int

iris.who.int

World Health Organization (2007). "Pneumococcal conjugate vaccine for childhood immunization—WHO position paper" (PDF). Weekly Epidemiological Record (12). ISSN 0049-8114.

wiley.com

onlinelibrary.wiley.com

Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; Lee, Jean; Levine, Ruth; Weizsäcker, Georg; Williams, Heidi (2006-10-02). "Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness". Health Economics. 16 (5) (published May 2007): 491–511. doi:10.1002/hec.1176. ISSN 1057-9230. PMID 17013993. S2CID 10511922.

worldcat.org

search.worldcat.org

Kremer, Michael; Levin, Jonathan; Snyder, Christopher M. (2020-05-01). "Advance Market Commitments: Insights from Theory and Experience". AEA Papers and Proceedings. 110: 269–273. doi:10.1257/pandp.20201017. ISSN 2574-0768.
Kremer, Michael (1998). "Patent Buyouts: A Mechanism for Encouraging Innovation". The Quarterly Journal of Economics. 113 (4): 1137–1167. doi:10.1162/003355398555865. ISSN 0033-5533. JSTOR 2586977. S2CID 31023203.
Kremer, Michael (January 2000). "Creating Markets for New Vaccines. Part I: Rationale". Innovation Policy and the Economy. 1: 35–72. doi:10.1086/ipe.1.25056141. ISSN 1531-3468. S2CID 153622261.
Kvåle, Gunnar (September 2001). "Tackling the diseases of poverty". The Lancet. 358 (9284): 845–846. doi:10.1016/s0140-6736(01)05996-7. ISSN 0140-6736. PMID 11570414.
Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael R.; Lee, Jean; Levine, Ruth; Weizsäcker, Georg; Williams, Heidi (2006-10-02). "Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness". Health Economics. 16 (5) (published May 2007): 491–511. doi:10.1002/hec.1176. ISSN 1057-9230. PMID 17013993. S2CID 10511922.
World Health Organization (2007). "Pneumococcal conjugate vaccine for childhood immunization—WHO position paper" (PDF). Weekly Epidemiological Record (12). ISSN 0049-8114.
Nayar, Anjali (2011-02-11). "Pneumococcal vaccine rolls out in developing world". Nature. doi:10.1038/news.2011.89. ISSN 1476-4687.
Usher, Ann Danaiya (May 18, 2019). "Low-cost pneumonia vaccine breaks into global market". The Lancet. 393 (10185): 2025–2026. doi:10.1016/s0140-6736(19)31084-0. ISSN 0140-6736. PMID 31106739. S2CID 155105175.